Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Significant Tricuspid Regurgitation.
Yujin YangMijin KimJun KimMin Soo ChoSahmin LeeJong-Min SongDae Hee KimPublished in: Journal of the American Heart Association (2024)
In this study, relative to warfarin, DOACs demonstrated comparable efficacy for ischemic stroke and systemic embolic events and major bleeding, with a lower intracranial hemorrhage risk in patients with significant TR and atrial fibrillation, indicating their effectiveness and safety.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- direct oral anticoagulants
- catheter ablation
- left atrial
- left atrial appendage
- aortic valve
- heart failure
- percutaneous coronary intervention
- mitral valve
- transcatheter aortic valve replacement
- venous thromboembolism
- left ventricular
- drug induced
- optical coherence tomography